Kentucky Access to Recovery Evaluation

Sponsor
Terry Bunn (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05889702
Collaborator
(none)
300
2
18
150
8.3

Study Details

Study Description

Brief Summary

Evaluate the long-term effectiveness of implementing vouchers as a linkage strategy in a population requiring recovery support services (RSS) when no other funding sources are available. A within-subjects study design will be used to test the effectiveness of the Kentucky Access to Recovery (KATR) last resort voucher linkage approach to reduce the risk of nonfatal and fatal overdoses by (a) increasing an individual's recovery capital; (b) reducing resumption of illicit substance use; and (c) promoting relinking to RSSs if illicit substance use is resumed.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: KATR Linkage Strategy

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of the Kentucky Access to Recovery (KATR) Linkage Strategy
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
KATR Clients

participants in the early stages of recovery and in substance use disorder (SUD) treatment; or those that have completed within the past year SUD treatment for opioid use disorder or stimulant use disorder or have a history of overdose from opioid use.

Behavioral: KATR Linkage Strategy
The Kentucky ATR (KATR) strategy is a 25-county program that links county residents at or below the 200% national poverty level who have an illicit SUD and are in treatment or early recovery to evidence-based RSSs such as recovery housing, and to other RSSs. The KATR linkage approach uses vouchers as a linkage strategy for individuals in SUD treatment who have no other funding options to acquire critical RSSs. As such, KATR's linkage through vouchers is a "last resort" approach for linking to RSSs.

Outcome Measures

Primary Outcome Measures

  1. Change in Recovery Capital per person [Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment]

    Recovery capital will be assessed using the Brief Assessment of Recovery Capital-10 (BARC-10); 10 item survey unidimensional measure of recovery capital, scores may range from 6-60 at any given time. Evaluation of the measure suggests that individuals who have a higher score are likely to reach or sustain a year or longer of recovery from substance use disorder.

  2. Change in number of drug overdoses per person [Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment]

    Number of drug overdoses will be assessed with the following survey question: In the past 30 days, did you experience an overdose or take too much of a substance that resulted in needing supervision or medical attention?

  3. Change in number of days of illicit substance use per person [Enrollment, Up to 6 months, 3 months post discharge, and 12 months post enrollment]

    Number of days illicit substance use will be assessed with the following survey question: During the past 30 days, how many days have you used any substance

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • be in SUD treatment or have completed within the past year SUD treatment for opioid use disorder or stimulant use disorder or have a history of overdose from opioid use

  • be a first-time participant in KATR

  • be in early stages of recovery (less than one year in recovery)

  • be a resident of a KATR service county

  • be at or below the 200% federal poverty level

  • not have financial resources available through other funding mechanisms for RSSs

  • be 18 years of age and older

  • be in need of recovery supports that will enhance their likelihood of staying in recovery

Exclusion Criteria:
  • Under 18

  • Participated in KATR previously

Contacts and Locations

Locations

Site City State Country Postal Code
1 FAHE Berea Kentucky United States 40403
2 University of Kentucky Lexington Kentucky United States 40506

Sponsors and Collaborators

  • Terry Bunn

Investigators

  • Principal Investigator: Terry Bunn, PhD, University of Kentucky

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Terry Bunn, Professor, University of Kentucky
ClinicalTrials.gov Identifier:
NCT05889702
Other Study ID Numbers:
  • 81811
  • R01CE003513-01-00
  • R01CE003513-01
First Posted:
Jun 5, 2023
Last Update Posted:
Jun 5, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Terry Bunn, Professor, University of Kentucky
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 5, 2023